Diet and coronary artery disease

Indian Heart Journal

Volumn 51, Issue 3, 1999, Pages 268-274

  Krishnamoorthy, K M ^a  

^a SRI SATHYA SAI INSTITUTE OF HIGHER MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; VEGETABLE OIL;

ARTICLE; BLOOD; CORONARY ARTERY DISEASE; DIET; FRUIT; HUMAN; RISK FACTOR; VEGETARIAN DIET;

CHOLESTEROL, LDL; CORONARY DISEASE; DIET; DIET, VEGETARIAN; FRUIT; HUMANS; PLANT OILS; RISK FACTORS;

EID: 0033122553     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Enas E A, Yusuf S, Mehta J. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992; 70: 945-949
2. Enas EA, Mehta JL. Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention and treatment. Clin Cardiol 1995; 18: 131-135
3. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996; 48: 343-354
4. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57: 5G-10G
5. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease: The Western Electric Study. N Engl J Med 1981; 304: 65-70
6. Shaper AG. Reflections on the Seven Countries Study. Lancet 1996; 347: 208
7. Schlant RC, Forman S, Stamler J, et al. For the Coronary Drug Project Research Group. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,384 men screened for the MRFIT. Am Heart J 1986; 112: 825-836
8. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982; 248: 1465-1477
9. Brensike JF, Levy RI, Kelsey SF. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: Results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 313-324
10. Blankenhorn DH, Aloupovic P, Wickham E, et al. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: Lipid and nonlipid factors. Circulation 1990; 81: 470-476
11. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990; 336: 129-136
12. Schuler G, Hambrecht R, Schlief G, et al. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 1992; 19: 39-42
13. Renaud S, Delorgel M. Dietary lipids and their relation to ischemic heart disease: From epidemiology to prevention. J Intern Med 1989; 225 (Suppl): 39-46
14. Schafer EJ, Lichtenstein EH, Lamon-Fava S, McNamara JR, Ordovas JM. Lipoproteins, nutrition, aging, and atherosclerosis [Letter]. Am J Clin Nutr 1995; 61 (Suppl): 726S-740S
15. Zock PL, de Vries JHM, Katan MB. Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy men and women. Artrioscler Thromb 1994; 14: 567-575
16. Spady DK, Woolet LA, Dietschy JM. Regulation of plasma LDL cholesterol levels by dietary cholesterol and fatty acids. Ann Rev Nutr 1993; 13: 355-381
17. Katan MB, Zock PI, Mesnick RP. Dietary oils, serum lipoproteins and coronary artery disease. Am J Clin Nutr 1995; 61(Suppl): 1368S-1373S
18. Willet WC, Acherio A. Response to the International Life Sciences report on trans fatty acids. Am J Clin Nutr 1995; 62: 524-526
19. Schmidt EB, et al. The potential of ω-3 fatty acids to reduce coronary artery disease. Proceedings of the Conference on ω-3 Fatty Acids in Nutrition and Vascular Biology. Houston, Texas, April 1994; pp 208-211
20. Samuelsson B, Hamberg M, Malmsten C, Svensson J. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. Adv Prostaglandin Thromboxane Res 1976; 1: 737-746
21. De Lorgeril, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha linoleic acid-rich diet in secondary prevention of CAD. Lancet 1994; 343: 1454-1459
22. Thorogood G, Carter R, Benfield L, et al. Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J 1987; 295: 351-353
23. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26 years follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977
24. McKeigue PM, Shah G, Marmott MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386
25. Tyroler HA. Epidemiology of plasma high-density lipoprotein cholesterol levels: The Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62 (Suppl IV, Part II): 1-3
26. Kannel WB, Gordon T. Physiological and medical concomitants of obesity: The Framingham Heart Study. In: Obesity in America. Bray GA, ed. Washington DC, 1979, US Department of Health, Education and Welfare; pp 125-163. NIH publication no. 79-359
27. Marmor A, Geltman EM, Schechtman K, et al. Recurrent myocardial infarction: Clinical predictors and prognostic implications. Circulation 1982; 66: 415-421
28. Glieberman L. Blood pressure and dietary salt in human populations. Ecol Food Nutr 1973; 2: 143-156
29. Intersalt Cooperative Research Group. Intersalt-An international study of electrolyte excretion and blood pressure: Results for 24-hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-328
30. Lynch SM, Gaziano JM, Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. Sub-Cell Biochem 1996; 25: 331-367
31. Ginter E. Cholesterol: Vitamin C controls its transformation to bile salts. Science 1973; 179: 702-704
32. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786
33. Trowell H. Ischemic heart disease and dietary fibre. Am J Clin Nutr 1972; 25: 926-932
34. Carlson E, Kipps M, Lockie A, Thomson JA. Comparative evaluation of vegan, vegetarian and omnivore diets. J Plant Foods 1985; 6: 89-100
35. Burr ML, Sweetnam PM. Vegetarianism, dietary fibre and mortality. Am J Clin Nutr 1982; 36: 873-877
36. Malhotra SL. Serum lipids, dietary factors and ischemic heart disease. Am J Clin Nutr 1967; 20: 462-479
37. Seelig MS, Heggtveit HA. Magnesium interrelationships in ischemic heart disease: A review. Am J Clin Nutr 1974; 27: 59-79
38. Cappucio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 1991; 9: 465-473
39. Ghafoorunisa, Krishnaswamy K. Dietary prescriptions: Diet and heart disease. Hyderabad: National Institute of Nutrition, 1994; pp 23-41
40. Haskell WL, Camargo C, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density lipoprotein subfractions. N Engl J Med 1984; 310: 805-810
41. Sanders TAB, Ellis FR, Dickerson JWT. Studies of vegans: The fatty acid composition of plasma choline phosphoglycerides erythrocytes, adipose tissue and breast milk and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls. Am J Clin Nutr 1978; 31: 805-813
42. Rouse IL, Beilin LJ, Mahoney DP, et al. Nutrient intake, blood pressure, serum and urinary prostaglandins and serum thromboxane B2 in a controlled trial with a lacto-ovo-vegetarian diet. J Hypertens 1986; 4: 241-250
43. Beilin LJ, Rouse IL, Armstrong BK, et al. Vegetarian diet and blood pressure levels: Incidental or causal association? Am J Clin Nutr 1988; 48: 806-810
44. Enas EA. Cooking oils, cholesterol and CAD: Facts and myths. Indian Heart J 1996; 48: 423-428
45. De Lorgeril M, Salen P, Martin J, Mamelle N, Monjaud I, Touboul P, et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease: Insights into the cardioprotective effects of certain nutriments. J Am Coll Cardiol 1996; 28: 1103-1108
46. Lopez-Segura, Velasco F, Castro P, Ordovas JM, Pednera RL, Blanlo A, et al. Monounsaturated fatty acid-enriched diet decreases plasminogen activator inhibitor type I. Arterioscler Thromb 1996; 16: 82-88
47. Burr ML, Fehily AM, Filbert JF, et al. Effects of changes in fat, fish and fibre intake on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; ii: 757-761
48. Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with acute myocardial infarction: Results of one year follow-up. Br Med J 1992; 304: 1015-1019
49. Arntzenius AC, Kromhout D, Barth JD, et al. Diet, lipoproteins, and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N Engl J Med 1985; 312: 805-811
50. Reddy KS, Shah P, Shrivastava U, Prabhakaran D, Joshi M, Puri SK, et al. Coronary heart disease risk factors in an industrial population of north India. Can J Cardiol 1997; 13 (Suppl B): 3-9
51. Ulbright TLV, Southgate TAT. Coronary heart disease: Seven dietary factors. Lancet 1991; 338: 985-992
52. Hunink MGM, Goldman L, Tosteson A, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary artery disease, 1980-1990. JAMA 1997; 277: 535-542
53. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988; 148: 36-69
54. Enas EA, Mehta JL. Malignant coronary artery disease in young Asian Indians: Thoughts on pathogenesis, prevention and therapy. New Engl J Med 1995; 333: 1301-1307
55. Bordia A, et al. The protective action of essential oils of onion and garlic in cholesterol-fed rabbits. Atherosclerosis 1975; 22: 103-110